TESORAI REFINE
LIVE

Serial Number

98596145

Owner

Tesorai, Inc.

Attorney

Trevor A. Caudle, Esq.

Filing Date

Jun 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TESORAI REFINE Trademark

Serial Number: 98596145

TESORAI REFINE is a trademark filed by Tesorai, Inc. on June 11, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Tesorai, Inc. (3 trademarks)

3525 Del Mar Heights Rd
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

June 11, 2024

Registration Date

Not Registered

Goods & Services

Downloadable computer software, and recorded computer software featuring technology that assists researchers in identification of biologically-relevant hits in high-throughput assays

Providing an online non-downloadable interactive web-based Software as a Service (SaaS) platform featuring software that assists researchers in identification of biologically-relevant hits in high-throughput assays; Scientific and technological services as well as research and design services relating thereto, namely, research services to support pharmaceutical and biotech research and clinical development; Industrial analysis and research services, namely, mass spectrometry services and life sciences research services; Scientific research; Consultancy relating to laboratory testing; Data analytics services in the life sciences industry, namely, raw data preprocessing via artificial intelligence-enabled pipelines that preprocess mass spectrometry and sequencing data; Data filtering and ranking services in the life sciences industry, namely, the development of algorithms to optimize ranking of interactions and hits from mass spectrometry and sequencing data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Development of computational models in the life sciences industry that predict interactions from mass spectrometry and sequencing data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Development of analytical approaches to generate novel biology and disease insights both from models and data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 31, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 31, 2024 GNSL
SUSPENSION LETTER WRITTEN
Dec 31, 2024 CNSL
ASSIGNED TO EXAMINER
Dec 30, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2024 NWOS
NEW APPLICATION ENTERED
Jun 11, 2024 NWAP